Fennec Pharma
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
68 Tw Alexander Dr, Durham, North Caroli...Phone Number
(919) 636-4530Website
www.fennecpharma.comRevenue
$51 MillionStock Symbol
FENCIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Fennec Pharma
Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina, that specializes in developing and commercializing therapies to reduce the risk of hearing loss caused by platinum-based chemotherapy, particularly in pediatric patients. Its flagship product, PEDMARK®, a formulation of sodium thiosulfate, is designed to prevent platinum-induced ototoxicitya serious side effect of cisplatin chemotherapyin children with localized, non-metastatic solid tumors, and has received FDA approval. A related formulation, PEDMARQSI®, has been authorized for pediatric use in Europe and the U.K., and is being commercialized internationally through an exclusive licensing partnership with Norgine Pharmaceuticals Ltd.Explore more
Fennec Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fennec Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Fennec Pharma is spiking on competitors!
Fennec Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Fennec Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Fennec Pharma
Funding: Get notified immidiatlly once Fennec Pharma has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Fennec Pharma had a recent Job posting/layoffs
Earning: See what the market has to say on Fennec Pharma recently announced quarterly report
Product Launch: Get notified when Fennec Pharma launches new products
Recommended Actions
Reach out to Masked Content who joined Fennec Pharma as Masked Content
Find 2 more new buyers
Compare Similar Companies to Fennec Pharma
Compare insights from companies similar to Fennec Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Fennec Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Fennec Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Fennec Pharma.
Fennec Pharma financials insights
Gather financial insights about Fennec Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Private Equity
$45M
Fennec Pharma Tech Stack
A closer look at the technologies used by Fennec Pharma
See more technologies
Most Recent Scoops
Project
, according to a high-level source in medical, is planning to release a request for proposal (RFP) for initiatives related to wearable medical technology within the next twelve months. Fennec Pharmaceuticals will be decreasing funding to support these efforts.
Spending/Investment, Request for Proposal (RFP), Financial Planning, Pharmaceuticals, Healthcare Technology
Project
, according to a high-level source in medical, is planning to begin initiatives related to quality improvement within six to nine months.
Quality Management
Project
, according to a high-level source in medical, is in the midst of initiatives related to pharmacy management systems.
Software, Pharmaceuticals, Healthcare Technology
Project
, according to a high-level source in medical, is in the midst of initiatives related to medical equipment. The organization is currently evaluating various vendors. Fennec Pharmaceuticals will be decreasing funding to support these efforts.
Spending/Investment, Financial Planning, Pharmaceuticals, Healthcare Technology
Project
Spending/Investment, Financial Planning, Machine Learning, Software, Language Technology, Pharmaceuticals, Artificial Intelligence, Language
Fennec Pharma News & Media
Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
~ 2026 Second Quarter Net Product Sales of $17.1 Million, Up 78% Year over Year ~Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026
RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its second quarter 2026 financial results before the opening of the U.S. financial markets on Tuesday, August 11, 2026. Management will host a conference call and webcast that day to discuss the Company’s financial and business results.Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
RESEARCH TRIANGLE PARK, N.C., June 15, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 10,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 15, 2026Fennec Announces Results of Annual Meeting
RESEARCH TRIANGLE PARK, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 28, 2026 were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held online on June 10, 2025.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fennec Pharma
Sign Up For FreeTo access detailed company insights
Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina, that specializes in developing and commercializing therapies to reduce the risk of hearing loss caused by platinum-based chemotherapy, particularly in pediatric patients. Its flagship product, PEDMARK®, a formulation... Read More
